Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

SLXP 159.11 +0.45 (0.28%)
price chart
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today
"We rate SALIX PHARMACEUTICALS LTD (SLXP) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover.
Allergan, Seeking to Fend Off Hostile Bid, Approaches Salix  Wall Street Journal
Salix Gains 15.5% After News Of Potential Acquisition By Allergan  Bidness Etc
Related articles »  
Salix Surges On Early Termination Of Takeover Review
Salix Pharmaceuticals, Ltd. (SLXP) stock price went vertical midday today, when the company announced that the US antitrust review over its acquisition of Cosmo Pharmaceuticals S.p.
Salix Announces Early Termination of HSR Waiting Period for Pending Transaction  MarketWatch
Related articles »  
Pharma Equities Technical Analysis -- Sanofi, AstraZeneca, Novartis, Salix ...
Investor-Edge has initiated coverage on the following equities: Sanofi SNY, +0.00% AstraZeneca PLC AZN, +2.38% Novartis AG NVS, +0.12% Salix Pharmaceuticals Ltd SLXP, +0.28% and AcelRx Pharmaceuticals Inc. ACRX, +0.42% Free research on these ...
Related articles »  
Today's Unusual Social Activity Stock: Salix Pharmaceuticals (SLXP)
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan
Salix Pharmaceuticals Ltd. (SLXP - Analyst Report) shares surged 15.5% after The Wall Street Journal claimed that Allergan Inc. (AGN - Analyst Report) has approached Salix to acquire it.
Related articles »  
Salix Pharmaceuticals Ltd (NASDAQ:SLXP) Shares Soars on Takeover Bid from ...
Shares of Salix Pharmaceuticals Ltd (NASDAQ:SLXP) was in the spotlight recently as a possible axqustion candidate for Allergan (NYSE:AGN), the manufacturer of Botox.
Salix Pharmaceuticals Ltd (NASDAQ:SLXP) ...
Shares of Salix Pharmaceuticals Ltd (NASDAQ:SLXP) was in the spotlight recently as a possible axqustion candidate for Allergan (NYSE:AGN), the manufacturer of Botox.
Related articles »  
Salix Pharmaceuticals Larger Than S&P 500 Component Expedia
... capitalization (factoring in those share counts) creates a true ´┐Żapples-to-apples´┐Ż comparison of the value of two stocks. In the case of Salix Pharmaceuticals Ltd (NASD: SLXP), the market cap is now $10.04B, versus Expedia Inc (NASD: EXPE) at $10.00B.
Related articles »  
Sector Update: Health Care Stocks Close Mostly Higher; Salix Pharma Surges ...
In company news, Salix Pharmaceuticals Ltd. ( SLXP ) climbed to a new, all-time high Tuesday after the maker of gastrointestinal medications said Allergan ( AGN ) reportedly approached the company in a bid to fight off a $53 billion hostile takeover by ...
Related articles »  
Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's Post-Market Laggard Stock
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Salix Pharmaceuticals Reports 2Q2014 Results  MarketWatch
Analyst Downgrades: Thoratec Corporation, Volcano Corporation, and Salix ...  Schaeffers Research (blog)
Related articles »